Reduction in risk of progression of diabetic retinopathy.
Klein
Barbara E K
BE
D000959:Antihypertensive Agents / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D003930:Diabetic Retinopathy / Q000517:prevention & control*; D018450:Disease Progression; D004359:Drug Therapy, Combination; D011345:Fenofibrate / Q000627:therapeutic use*; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D019821:Simvastatin / Q000627:therapeutic use
D000959:Antihypertensive Agents; D011345:Fenofibrate; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D000960:Hypolipidemic Agents; D019821:Simvastatin